Rakovina Stock Today
| RKV Stock | CAD 0.11 0.00 0.00% |
|
|
Rakovina Therapeutics is selling for under 0.11 as of the 3rd of October 2023; that is No Change since the beginning of the trading day. The stock's lowest day price was 0.11. Rakovina Therapeutics has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Rakovina Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of August 2023 and ending today, the 3rd of October 2023. Click here to learn more.
Certain Worldwide Rights of NewGen Therapeutics, Inc. comprises PARP inhibitor program technology. RAKOVINA THERAPEUTICS is traded on Commodity Exchange in Exotistan. The company has 69.83 M outstanding shares of which 1.42 K shares are at this time shorted by private and institutional investors with about 0.2 days to cover all short positions. More on Rakovina Therapeutics
Moving together with Rakovina Stock
| + | 0.69 | PYPL | PayPal Holdings CDR | PairCorr | ||
| + | 0.66 | RCI-A | Rogers Communications | PairCorr | ||
| + | 0.66 | RCI-B | Rogers Communications | PairCorr |
Moving against Rakovina Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Rakovina Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Rakovina Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Rakovina Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Macroaxis Advice The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Rakovina Therapeutics' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details Strong SellOvervalued |
Rakovina Therapeutics (RKV) is traded on TSX Venture Exchange in Canada and employs 3 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.98 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Rakovina Therapeutics's market, we take the total number of its shares issued and multiply it by Rakovina Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Rakovina Therapeutics classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 69.83 M outstanding shares of which 1.42 K shares are at this time shorted by private and institutional investors with about 0.2 days to cover all short positions.
Rakovina Therapeutics has accumulated about 4.37 M in cash with (1.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.
Check Rakovina Therapeutics Probability Of Bankruptcy
OwnershipRakovina Therapeutics has a total of 69.83 Million outstanding shares. Rakovina Therapeutics has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Ownership Allocation
Check Rakovina Ownership DetailsRakovina Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Rakovina Therapeutics market risk premium is the additional return an investor will receive from holding Rakovina Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Rakovina Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Rakovina Therapeutics' alpha and beta are two of the key measurements used to evaluate Rakovina Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.92 | |||
| Standard Deviation | 7.56 | |||
| Variance | 57.18 | |||
| Risk Adjusted Performance | (0.00042195) |
Rakovina Stock Against Markets
Picking the right benchmark for Rakovina Therapeutics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Rakovina Therapeutics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Rakovina Therapeutics is critical whether you are bullish or bearish towards Rakovina Therapeutics at a given time. Please also check how Rakovina Therapeutics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Rakovina Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
How to buy Rakovina Stock?
Before investing in Rakovina Therapeutics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Rakovina Therapeutics. To buy Rakovina Therapeutics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Rakovina Therapeutics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Rakovina Therapeutics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Rakovina Therapeutics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Rakovina Therapeutics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Rakovina Therapeutics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Rakovina Therapeutics?
The danger of trading Rakovina Therapeutics is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Rakovina Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Rakovina Therapeutics. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Rakovina Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rakovina Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the CEO Directory module to screen CEOs from public companies around the world.
Complementary Tools for Rakovina Stock analysis
When running Rakovina Therapeutics' price analysis, check to measure Rakovina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rakovina Therapeutics is operating at the current time. Most of Rakovina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rakovina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rakovina Therapeutics' price. Additionally, you may evaluate how the addition of Rakovina Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |